Spots Global Cancer Trial Database for omission of anthracyclines
Every month we try and update this database with for omission of anthracyclines cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo | |
Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer | NCT02102438 | Breast Cancer HER-2 Positive ... | Trastuzumab Weekly Paclitax... Carboplatin | 65 Years - | Instituto do Cancer do Estado de São Paulo |